These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. Tsoukas CD, Watry D, Escobar SS, Provvedini DM, Dinarello CA, Hustmyer FG, Manolagas SC. J Clin Endocrinol Metab; 1989 Jul 15; 69(1):127-33. PubMed ID: 2525134 [Abstract] [Full Text] [Related]
15. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression. Tilden AB, Balch CM. Surgery; 1982 Sep 15; 92(3):528-32. PubMed ID: 6287658 [Abstract] [Full Text] [Related]
16. Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism of monocyte modulation of clonal expansion. Bockman RS, Rothschild M. J Clin Invest; 1979 Sep 15; 64(3):812-9. PubMed ID: 313939 [Abstract] [Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes. Koren R, Ravid A, Rotem C, Shohami E, Liberman UA, Novogrodsky A. FEBS Lett; 1986 Sep 01; 205(1):113-6. PubMed ID: 3462028 [Abstract] [Full Text] [Related]